December 21, 2023
5,341
102
39
2.64%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
9:30Now PlayingDrug dealers are taking advantage of the UK supply shortage of ADHD medication - offering a month's supply of these controlled drugs for nearly £200.
Times Radio reporter, Jo Crawford, investigates how this shortage is pushing people with ADHD to dangerous lengths to prevent themselves from going into withdrawal.
Department of Health and Social Care spokesperson:
“We are working with manufacturers to resolve any issues with ADHD medicine supply in the UK as soon as possible to ensure all patients are able to access these medicines.
“We have advised NHS healthcare professionals on the management of ADHD patients whilst there continue to be disruptions to supplies. People should not self-medicate and buy regulated drugs from the internet and anyone with concerns is advised to speak to their clinician to discuss the suitability of treatment with alternative medicines where necessary.”
Dr Alison Cave, MHRA Chief Safety Officer said:
“Medicines approved in the UK to treat ADHD are prescription-only medicines. You should always obtain these medicines from a pharmacy and only when prescribed by an authorised healthcare professional.
“Buying such medicines from any other sources increases the risk of getting a product which is either falsified or not licensed for use in the UK. Products purchased in this way do not meet our strict quality and safety standards, and taking such medicines may put your health at significant risk.
“We ask you to speak to your doctor or pharmacist if you have any questions about your treatment. If you suspect that you’ve had a side effect to an ADHD medication or suspect it’s not a genuine product, please report it to our Yellow Card scheme.”
Times Radio is awaiting comment from Takeda Pharmaceuticals.
📻 Listen to Times Radio
📍 Subscribe to our channel
🗞 Subscribe to The Times
📲 Get the free Times Radio app
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.